EMA Says There Has Been An Increase In Demand For Trulicity, Which Has Led To Supply Shortages That Are Expected To Continue Through September 2023
Portfolio Pulse from Happy Mohamed
The European Medicines Agency (EMA) has reported an increase in demand for Trulicity, leading to supply shortages. These shortages are expected to continue through September 2023.
August 28, 2023 | 2:47 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Eli Lilly and Company, the manufacturer of Trulicity, may face revenue impacts due to the reported supply shortages.
Eli Lilly and Company, the manufacturer of Trulicity, is directly impacted by the reported supply shortages. The increased demand for Trulicity indicates a potential increase in revenues, but the supply shortages could limit the company's ability to meet this demand, potentially impacting revenues negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100